Sort
53,477 grants matching “addiction”
OTHER FUNCTIONS: NIDA BLENDING RESEARCH AND PRACTICE, N01DA-11-1145. AUGUST 15, 2011 - AUGUST 14, 2015.
$839,693Katia Delrahim-Howlet · Synergy Enterprises, Inc. · N01 · FY2014 · DA
Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine
$839,533David J Volsky · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · DA
Discovery Proteomics Core
$839,271Tukiet T Lam · Yale University · P30 · FY2025 · DA
Development of Novel Therapeutics for Methamphetamine Abuse
$839,154Linda P Dwoskin · University Of Kentucky · U01 · FY2019 · DA
Health Systems Node of the NIDA Clinical Trials Network
$839,126Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2023 · DA
Oncogenic mechanisms and molecular targets in myeloma
$838,914Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
RNA interference-based screens for molecular targets in cancer
$838,914Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Comprehensive, tailored, technology-based intervention to improve virologic suppression among youth and young adults living with HIV
$838,883Parya Saberi · University Of California, San Francisco · R01 · FY2025 · MH
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency
$838,842Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2017 · DA
Maternal Lifestyles Study Phase V
$838,739Seetha Shankaran · Wayne State University · U10 · FY2008 · DA
Synaptic integration and intrinsic firing properties of basal ganglia neurons
$838,682Zayd M Khaliq · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Molecular underpinnings of the developmental Effects of Cannabis
$838,504Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA
Appalachian Node
$838,320Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2025 · DA
JCOIN Phase II Economic Research Resource Center
$838,200Sean M. Murphy · Weill Medical Coll Of Cornell Univ · U24 · FY2025 · DA
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder
$837,882Elena Molokanova · Neurano Bioscience · R44 · FY2024 · DA
Cognitive Reappraisal for Mitigating Incubation of Cocaine Cue-Reactivity
$837,812Muhammad Adeel Parvaz · Icahn School Of Medicine At Mount Sinai · R37 · FY2024 · DA
Cognitive Reappraisal for Mitigating Incubation of Cocaine Cue-Reactivity
$837,812Muhammad Adeel Parvaz · Icahn School Of Medicine At Mount Sinai · R37 · FY2025 · DA
Translational Center on Serotonin and Stimulant Addiction
$837,809Kathryn A. Cunningham · University Of Texas Med Br Galveston · P20 · FY2008 · DA
Technology Improving Success of Medication-Assisted Treatment in Primary Care
$837,803Steven Paul Jenkins · Q2i, Llc · R42 · FY2020 · DA
Randomized-controlled trial of virtual reality for chronic low back pain to improve patient-reported outcomes and physical activity
$837,772Brennan Spiegel · Cedars-Sinai Medical Center · UH3 · FY2022 · AR
Randomized-controlled trial of virtual reality for chronic low back pain to improve patient-reported outcomes and physical activity
$837,772Brennan Spiegel · Cedars-Sinai Medical Center · UH3 · FY2021 · AR
Novel Nanovaccines Against Nicotine Addiction
$837,709Chenming M Zhang · Virginia Polytechnic Inst And St Univ · U01 · FY2015 · DA
Translational Center on Serotonin and Stimulant Addiction
$837,530Kathryn A. Cunningham · University Of Texas Med Br Galveston · P20 · FY2009 · DA
IND-enabling development of a long-duration antagonist to treat opioid overdose
$837,364Lawrence J Zana · Consegna Pharma, Inc. · R44 · FY2024 · DA
SCOR on Sex and Gender Factors Affecting Women's Health
$837,145Medical University Of South Carolina · P50 · FY2002 · DA